Home
About
Overview
Sharing Data
ORCID
Help
History (1)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst. 2016 Feb; 108(2).
View in:
PubMed
subject areas
Adult
Aged
BRCA2 Protein
Breast Neoplasms
Codon, Terminator
Female
Genetic Predisposition to Disease
Heterozygote
Humans
Logistic Models
Lysine
Male
Middle Aged
Neoplasm Invasiveness
Odds Ratio
Ovarian Neoplasms
Polymorphism, Single Nucleotide
Prostatic Neoplasms
Risk Assessment
Risk Factors
authors with profiles
Peter Hulick
Olufunmilayo Olopade